Terpenoid-type quinones for treatment of diabetes
US5674900A · kind A · utility
23Cited by
3References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 1, 1995 |
| Grant date | Oct 7, 1997 |
| Priority date | — |
| Expiry date | Aug 1, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C59/90
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel terpenoid-type quinones which can be obtained from Pycnanthus spp., processes for obtaining the novel terpenoid-type quinones and methods for their use as hypoglycemic agents, for example, in the treatment of diabetes are described. In a preferred embodiment, the novel terpenoid-type quinones are obtained from the leaves and stems of Pycnanthus angolensis. As agents for the treatment of diabetes, the novel terpenoid quinones are useful for treating insulin-dependent (type I) and/or non-insulin-dependent (type II) diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.